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Abstract
Background: Suicide is a significant public health issue with almost one million people dying by suicide each year
worldwide. Deliberate self harm (DSH) is the single most important risk factor for suicide yet few countries have reliable data
on DSH. We developed a national DSH registry in the Republic of Ireland to establish the incidence of hospital-treated DSH
at national level and the spectrum and pattern of presentations with DSH and repetition.
Methods and Findings: Between 2003 and 2009, the Irish National Registry of Deliberate Self Harm collected data on DSH
presentations to all 40 hospital emergency departments in the country. Data were collected by trained data registration
officers using standard methods of case ascertainment and definition. The Registry recorded 75,119 DSH presentations
involving 48,206 individuals. The total incidence rate fell from 209 (95% CI: 205–213) per 100,000 in 2003 to 184 (95% CI:
180–189) per 100,000 in 2006 and increased again to 209 (95% CI: 204–213) per 100,000 in 2009. The most notable annual
changes were successive 10% increases in the male rate in 2008 and 2009. There was significant variation by age with peak
rates in women in the 15–19 year age group (620 (95% CI: 605–636) per 100,000), and in men in the 20–24 age group (427
(95% CI: 416–439) per 100,000). Repetition rates varied significantly by age, method of self harm and number of previous
episodes.
Conclusions: Population-based data on hospital-treated DSH represent an important index of the burden of mental illness
and suicide risk in the community. The increased DSH rate in Irish men in 2008 and 2009 coincided with the advent of the
economic recession in Ireland. The findings underline the need for developing effective interventions to reduce DSH
repetition rates as a key priority for health systems.
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Introduction
Suicide is a significant public health issue with almost one
million people dying by suicide each year worldwide, representing
an annual global suicide mortality rate of 16 per 100,000 [1].
Deliberate self harm (DSH) is the single most important risk factor
for suicide [2,3]. UK studies have estimated that in the year after
an act of DSH the risk of suicide is 30–50 times higher than in the
general population [4,5]. Self-inflicted injuries are the sixth leading
cause of ill-health and disability worldwide [6]. In England, it is
estimated that there are 220,000 hospital attendances annually
due to DSH [7].
DSH frequently leads to non-fatal repetition with worldwide
studies giving an estimated median risk of repetition of 16% within
one year and 23% over four years of follow-up [5]. Subsequent
repeated self harm often occurs within days of a DSH act [8,9].
A UK multicentre study showed a repetition rate of 19% within
one year of an index case but analysis based on all observed
DSH presentations gave a much higher rate of repeated DSH
(33%) [10].
Few countries worldwide have reliable data on DSH [11].
There is a broad spectrum of self harming behaviours ranging
from deliberate recklessness to highly lethal attempts at suicide and
only a minority of adolescents and adults who self harm presents to
hospital [12,13].
An internationally-agreed definition of DSH has been endorsed
by the WHO. This definition facilitated international comparison
in incidence and trends in a European multicentre study which
demonstrated more than 10-fold variation in rates across more
than 20 regions [14]. These incidence rates were based on single
centres and reliable estimates of national rates are not available.
We have established a national DSH registry in the Republic of
Ireland. The purpose of this national registry is to determine and
monitor the incidence and repetition of the problem, to identify
high-incidence groups and areas and to inform services and
practitioners concerned with the prevention of suicidal behaviour.
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In the current paper, we present person-based rates of DSH at
national level together with data on the spectrum and pattern of
DSH presentations and risk of repetition in the Republic of
Ireland over the seven-year period 2003–2009.
Methods
Ethics Statement
Ethical approval was granted by the National Research Ethics
Committee of the Faculty of Public Health Medicine. The Ethics
Committee and the Irish Data Protection Agency gave approval to
the Registry operating without obtaining informed patient
consent. The National Suicide Research Foundation is registered
with the Data Protection Agency and complies with the Irish Data
Protection Act of 1988 and the Irish Data Protection (Amend-
ment) Act of 2003.
Setting and coverage
The population of the Republic of Ireland increased by 12% to
almost 4.5 million in the study period 2003–2009. During this
period, 40 hospitals operated emergency departments (EDs) in
Ireland. The number of hospitals that contributed full calendar
year data to the Registry increased from 37 hospitals for 2003 to
38 for 2004–2005 and all 40 hospitals for 2006–2009.
Definition of deliberate self harm
The Registry uses the following as its definition of deliberate self
harm: ‘an act with non-fatal outcome in which an individual
deliberately initiates a non-habitual behaviour, that without
intervention from others will cause self harm, or deliberately
ingests a substance in excess of the prescribed or generally
recognised therapeutic dosage, and which is aimed at realising
changes that the person desires via the actual or expected physical
consequences’ [14]. This definition was derived for the WHO
study and it is consistent with that used in the UK Multicentre
study [7]. The definition includes acts involving varying levels of
suicidal intent and various underlying motives such as loss of
control, cry for help or self-punishment.
Data items and coding
The Registry core dataset includes the following variables:
patient initials recorded in an encrypted format, gender, date of
birth, area of residence coded to administrative area (electoral
division), date and hour of attendance at hospital, method(s) of self
harm, drugs taken (if applicable), and recommended next care.
The method(s) of self harm were recorded according to the Tenth
Revision of the WHO’s International Classification of Diseases
codes for intentional injury (X60–X84). In cases where more than
one method of self harm was used, all were recorded. For cases of
self harm involving alcohol, the code X65 was recorded. Data
items that are not routinely available in emergency department
charts and records, such as suicide intent and psychiatric
diagnosis, are not recorded by the Registry.
Data collection and quality assurance
All data were collected by data registration officers who
operated independently of the hospitals and followed the
Registry’s standardised methods of case ascertainment. In 36
hospitals, all electronic or paper-based records of attendances to
the ED were checked manually by the data registration officers. In
four hospitals, a two-stage process has been developed whereby a
keyword search is first undertaken of the free-text field in the ED’s
IT system which records the reason for the presentation as
completed by the triage nurse. All presentations flagged as
potential cases by the keyword search are then examined by the
data registration officer. From 2003 through 2005, Registry data
were recorded on pre-printed forms that were optically scanned at
the Registry offices with data capture using an integrated high
resolution character recognition software and scanner system.
From 2006, the Registry has recorded data onto laptop computers
via a customised data entry and electronic transfer system.
All data registration officers receive standard training in the
Registry data collection methods and procedures and attend
biannual update meetings which review case definitions and
related quality control issues. In 2004 and 2005, a quality control
exercise was carried out whereby a pair of data registration officers
each independently collected data from two hospitals for the same
consecutive series of attendances to the ED. High levels of
agreement were found between the data registration officers in
terms of case ascertainment, with Kappa statistics of 0.97 in 2004
and 0.95 in 2005.
Data analysis
Encrypted patient initials, date of birth and gender were the
data items used to distinguish between DSH patients and to
identify repeat presentations by the same patients. The Registry
recorded 243 presentations in 2003–2009 lacking at least one of
these data items. These cases constituted just 0.3% of all recorded
cases and were excluded from all analyses presented here.
The annual incidence rate per 100,000 population was
calculated for the total, male and female population (and for
age-sex subgroups) based on the number of persons who presented
to hospital following DSH in each calendar year. Where
appropriate, direct standardisation was carried out using the
European Standard Population [15]. Population data were
derived at all required levels of disaggregation from the National
Census 2006. Annual population estimates provided by the Irish
Central Statistics Office were used for non-censal years if available
at the required level of disaggregation. Exact Poisson 95%
confidence intervals were calculated for the rates using StatsDirect
version 2.7.7.
The year 2006 was the first year that all 40 hospital EDs in the
Republic of Ireland contributed data to the Registry as in 2003 the
Registry had data from 37 hospitals and in 2004–2005 there were
data from 38 hospitals. Using 2006, the national incidence rates
reported in the paper were estimated in three ways: based on data
from all 40 hospitals (rate 1), based on data from the 37 hospitals
that contributed to the Registry in 2003 (rate 2) and based on the
data from the 38 hospitals that contributed to the Registry in
2004–2005 (rate 3). Relative differences were calculated for 2003
(i.e. rate 1 divided by rate 2) and 2004–2005 (rate 1 divided by rate
3). These relative differences were then applied to the rates
calculated using the available 2003 and 2004–2005 data.
A repeat DSH episode was defined as re-presentation to any
hospital ED due to a further act of self harm undertaken after
leaving hospital following treatment in an ED for a previous act of
DSH.
The repeat event analysis used was conditional risk set analysis
[16,17]. This analysis examined age, gender, method of self harm,
and the number of previous self harm episodes as possible risk
factors for repetition. Univariate results were presented using a
series of Kaplan-Meier cumulative incidence curves. Multivariate
analysis used a Cox proportional hazard model. We used a robust
analysis that modified the variance of the estimates to account for
lack of independence between DSH presentations by a given
individual. Analyses involving the number of previous DSH
presentations were confined to persons whose first observed
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presentation was made after 1 January 2006 (i.e. no DSH
presentation in 2003–2005).
The time from the start of follow-up, 1 January 2006, until a
subject’s index event may reflect a subject’s underlying risk of
DSH. We considered a model that included an additional
adjustment for this lead-in time. While increased lead-in time
was associated with reduced risk of repetition, adjustment for it did
not impact on the results for the factors of interest.
When the final date of the study is fixed, 31 December 2009 in
this case, the potential follow-up time will depend on when a
subject enters the study. Individuals with high risk of repetition
would be expected to enter the study sooner and so have a longer
potential follow-up time. This leads to informative censoring that
can bias final estimates [18]. To address this, we limited follow-up
after a self harm presentation to 12 months. Events that occurred
after 12 months were censored and we only followed subjects who
presented before 2009. This ensured that all subjects had the same
potential follow-up of one-year and means that repetition risk
measures related to repetition within 12 months. The assumption
of proportional hazards was tested graphically. Analysis was
carried out using Stata 11.
Results
Deliberate self harm 2003–2009
For the period 2003–2009, the Registry recorded 75,119 DSH
presentations to hospital EDs in Ireland, involving a total of 48,206
individuals. The average annual total, male and female rate of
persons presenting with self harm were 198 (95% CI: 196–200), 173
(95% CI: 171–175) and 224 (95% CI: 221–226) per 100,000,
respectively. The total incidence rate fell by 2–6% annually from
2003 (209 (95% CI: 205–213) per 100,000) to 2006 (184 (95% CI:
180–189) per 100,000) and then increased by 2–6% per year,
returning to 209 (95% CI: 204–213) per 100,000 in 2009. The most
notable annual changes were two successive 10% increases in the
male rate of DSH (from 162 (95% CI: 157–168) per 100,000 in
2007 to 179 (95% CI: 173–185) per 100,000 in 2008 and 197 (95%
CI: 191–203) per 100,000 in 2009). Overall, the female rate was
29% higher than the male rate though this sex difference reduced in
recent years from 38% in 2005 to just 13% in 2009.
Gender and age
There was substantial variation in the incidence of hospital-
treated DSH by age for both men and women (Figure 1a), with a
clear peak in 15–19 year-old women (620 (95% CI: 605–636) per
100,000), almost twice the equivalent male rate (336 (95% CI:
325–347) per 100,000). In men, the highest rate was observed in
the 20–24 year age group (427 (95% CI: 416–439) per 100,000).
However, this was marginally lower than the rate in 20–24 year-
old women (445 (95% CI: 433–457) per 100,000). DSH was
relatively rare in older people. In contrast there was an appreciable
incidence of DSH in late childhood and adolescence, particularly
in girls and in analyses by single year of age for the 10–24 year age
group the peak rate was at age 17 in girls (705 (95% CI: 669–743)
per 100,000) whereas the male rate peaked at age 20 years (460
(95% CI: 433–488) per 100,000; Figure 1b).
Method of deliberate self harm
Figure 2 shows variation by age in the method of DSH used by
men and women who presented to hospital EDs for treatment.
Drug overdose was by far the most common method of self harm
involved. It was the sole method used in 68% of all cases and more
so for women (75%) than for men (59%; P,0.001). The most
common types of drugs involved in intentional overdose acts were
minor tranquillisers (42% of all, 43% of male and 40% of female
overdose acts; P,0.001), paracetamol-containing medication
(30% of all, 24% of male and 34% of female overdose acts;
P,0.001) and anti-depressants/mood stabilisers (22% of all, 20%
of male and 24% of female overdose acts; P,0.001).
Self-cutting was the only other common method of self harm. It
was the sole method used in 16% of cases and this was more
commonly associated with male (20%) rather than female (13%;
P,0.001) presentations. Most cases involving self-cutting were minor
and did not require sutures (63% of all, 59% of male and 68% of
female cases; P,0.001). However, 6% of cases (8% of male and 4% of
female cases; P,0.001) were referred for plastic surgery assessment.
Among men, and to a lesser extent among women, the older the
self harm patient, the greater the likelihood that drug overdose was
used as the sole method of self harm (Figure 2). The corollary was
the relatively higher prevalence of self-cutting among the young
self harm patients. The more lethal methods of attempted hanging
and drowning were the only means of self harm involved in 3%
and 2% of presentations, respectively. It was indicated that alcohol
was involved in 41% of all DSH, in 45% of male and 38% of
female acts (P,0.001).
Repeated deliberate self harm
Of the 48,206 people whomade the 75,911 DSH presentations to
hospital in 2003–2009 that were recorded by the Registry, 10,516
(22%) presented on at least two occasions (at least one repeat), 4,642
(10%) presented at least three times (at least two repeats) and 453
(1%) presented at least ten times. This group of 453 frequent
repeaters accounted for 8,080 (11%) of the 75,911 self harm
presentations to hospital over the seven years of observation.
Risk of repetition
The results of a Kaplan-Meier analysis are presented in Figure 3.
Risk of repetition was highest in the time immediately after a DSH
presentation with almost half (45%) of all repeat events occurring
in the first 3 months and almost two-thirds (60%) in the first 6
months. Repetition rates were similar in men and women, 29% vs.
30% within 12 months. Risk of repetition within twelve months
increased from 18% in those younger than 15 years to 37% in
those aged 35–44 years and fell to 14% in those over 65 years.
There was a clear association between repetition and the method
of DSH with the highest rate observed in patients who used self-
cutting, either as the sole method or in combination with drug
overdose (Figure 3). Risk of repetition within twelve months of a
presentation was 39% and 40% in patients whose methods were
cutting only or cutting and overdose, respectively. In contrast, the
12-month risk of repetition for the drug overdose only group was
26% with a similar risk level for other methods. Risk of repetition
increased rapidly with the number of previous self harm
presentations. The 12-month repetition rate was 14%, 37%,
50%, 62%, and 70% for those with no, one, two, three and four
previous presentations.
Table 1 summarises the results of the multivariate Cox
regression analysis examining risk of repeated DSH. Results were
consistent with univariate results. For both genders the highest
repetition rate was in the 35–44 year age group although this was
only significant among female patients. Among men, patients aged
over 65 years were less likely to make a repeat presentation. Acts
involving self-cutting were associated with an elevated risk of
repetition for both genders but where cutting was the sole method
of DSH the increased risk of repetition among female patients was
significantly higher than that among male patients. Risk of
repetition increased rapidly with the number of previous DSH
presentations and in a similar manner for male and female
Hospital-Treated Deliberate Self Harm
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patients. An alternate analysis which stratified by number of
previous DSH presentations yielded similar risk estimates for the
age groups and methods of self harm.
Discussion
This study provides the first reliable national-level data on the
incidence and repetition of hospital treated self harm. In contrast
with suicide, national recording systems for DSH are absent.
Previous studies have reported on regional multicentre DSH data
within one country [7,19,20] or across multiple countries
[14,21,22] and these have demonstrated striking differences in
the incidence of hospital-treated DSH. However, patterns and
trends from one centre may be representative of others in the same
country as has been demonstrated in the UK [23] where the value
of DSH registries has been exemplified, most notably by the
Oxford Monitoring System for Attempted Suicide which has
contributed hugely to the understanding of suicidal behaviour
since its establishment in 1976.
Figure 1. Incidence of hospital-treated deliberate self harm by five-year age-sex group (A) and by single year of age for 10–24 year-
olds (B). (A) The annual rate per 100,000 population of male and female persons presenting to hospital as a result of deliberate self harm is shown by
five-year age group with error bars representing the 95% confidence interval around the rate. (B) The annual rate per 100,000 population of male and
female persons presenting to hospital as a result of deliberate self harm is shown by single year of age for 10–24 year-olds with error bars
representing the 95% confidence interval around the rate.
doi:10.1371/journal.pone.0031663.g001
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The findings from the Irish National Registry of Deliberate Self
Harm highlight the scale of the problem, the extent of variation by
age, gender, and the high rates of repeated DSH. The highest
DSH rates (700 per 100,000) were observed in 17 year-old girls.
Repetition rates were similar in men and women with 29% and
30% engaging in a repeat self harm act in twelve months follow-
Figure 2. Method of deliberate self harm (DSH) involved in male (A) and female (B) presentations to hospital in Ireland. The areas
illustrated in the charts represent the percentage of male and female deliberate self harm presentations involving different methods of self harm.
Variation in the areas across the X-axis illustrates the variation in the method of self harm used by age.
doi:10.1371/journal.pone.0031663.g002
Figure 3. Kaplan-Meier failure curves showing the cumulative probability of a repeated deliberate self harm (DSH) presentation.
The curves illustrate the cumulative probability of a repeated deliberate self harm (DSH) presentation to hospital in the twelve month period after an
index DSH presentation. Variation in the probability of a repeated DSH presentation is shown by age group (A), by method of DSH (B) and by number
of previous DSH presentations.
doi:10.1371/journal.pone.0031663.g003
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up, respectively. Risk of repetition is highest in the days and weeks
following each presentation.
The findings on the pattern of self harm presentations to
hospital by gender, age and method are broadly similar to previous
studies in other countries. In particular, the higher rate in women,
the peak in early adult life and the predominance of drug overdose
as a method of self harm seem to be consistent across difference
cultures [24–26]. However, rates of self-cutting particularly in men
are higher in Ireland than in most other regions in Europe [14].
One previous study also found an over representation of men
among self-cutting patients. Compared to overdose patients, they
were more often single, lived alone, were unemployed, had a
history of previous DSH and misused alcohol [27]. The Irish
Registry data show that men inflict more severe damage when self-
cutting compared to women which has also been shown elsewhere
[28]. This suggests that greater lethality may be the reason for our
observed over representation of men among self-cutting patients.
The one-year risk of non-fatal repetition of 29% in men and
30% in women is considerably higher than that estimated from a
2002 systematic review of 90 observational and experimental
studies [5] but is similar to the findings of more recent Irish and
UK studies which also took an event-based rather than person-
based approach to the analysis of repetition [10,29]. The high rate
of repetition in the period immediately following each episode is
also consistent with previous work [9]. Risk of DSH repetition rose
sharply with increasing numbers of previous self harm presenta-
tions. There was a 70% risk of a repeat self harm presentation
within twelve months among individuals with four previous
presentations. This is in line with Haw et al who found that past
history of DSH was the best predictor of both frequent (4+) and
less frequent (1–3) repetitions [30].
As with most previous research, there was no reliable clinical
record of the total number of previous self harm acts engaged in by
the DSH patient who presented to hospital. Therefore, it was not
possible to directly estimate the one-year repetition rate of patients
who engaged in DSH for the first time, i.e. an inception cohort.
However, we feel that our follow-up of patients who presented to
hospital for the first time in at least three years will closely
approximate the one-year risk of an inception cohort. The high
levels of repeated DSH underline the need for suitably-trained
health professionals to assess both the risk of repeated suicidal
behaviour and the broader psychosocial needs of DSH patients
attending hospital EDs and to make appropriate referral and
provision for follow-up [31,32]. However, the provision of
assessments to DSH patients has been shown to vary considerably
by hospital [33].
In terms of effective treatment interventions reducing risk of
repeated self harm, there is a growing evidence base supporting
the efficacy of cognitive behaviour therapy, problem-solving
therapy and interpersonal psychotherapy [34–36]. For borderline
personality disorder patients who frequently engage in repeated
DSH, dialectical behaviour therapy has consistently shown
positive effects in reducing risk of repetition [35]. There is also
evidence of efficacy for less intensive interventions as reduced
repetition rates have been found among DSH patients who
received postcard reminders of the availability of services in the 24
months following discharge from hospital [37,38].
The increased DSH rate in Irish men in 2008 and 2009 was
paralleled by an increase in the male suicide rate and these
changes coincided with the advent of the economic recession in
Ireland. These findings are in line with Stuckler et al [39] and
Gunnell et al [40] and provide further evidence of the effect of
recession on rates of suicidal behaviour and the need for
preventative action.
The findings from the Irish National Registry of Deliberate Self
Harm in relation to repetition underline the importance of linking
DSH with suicide mortality data. Patients surviving an act of
attempted hanging or attempted drowning showed a relatively low
risk of non-fatal repetition. However, studies have shown their risk
of fatal repeat acts to be relatively high [41,42].
In conclusion, the findings from this study highlight the value of
a national registry of hospital-treated DSH as a health information
system with particular reference to monitoring demographic
trends and the identification of predictive factors for repetition
and monitoring the health response to this problem.
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Table 1. Results of multivariate Cox regression analysis
examining 12-month risk of repeated deliberate self harm
(DSH).
Hazard Ratio
(95% CI)
Hazard Ratio
(95% CI)
Male Female
Age group
,15 years 0.68 (0.41, 1.13) 1.25 (1.00, 1.56)
15 to 24 1.0 1.0
25 to 34 0.98 (0.87, 1.09) 1.20 (1.06, 1.34)
35 to 44 1.12 (0.99, 1.26) 1.34 (1.19, 1.49)
45 to 54 1.01 (0.87, 1.17) 1.15 (1.00, 1.31)
55 to 64 0.87 (0.70, 1.09) 1.12 (0.94, 1.34)
65 and over 0.51 (0.33, 0.79) 0.90 (0.66, 1.21)
Method
Overdose 1.0 1.00
Cutting 1.18 (1.06, 1.32) 1.57 (1.41, 1.75)
Overdose & Cutting 1.48 (1.23, 1.78) 1.48 (1.23, 1.76)
Hanging 0.96 (0.75, 1.23) 1.21 (0.93, 1.56)
Drowning 0.88 (0.72, 1.09) 1.07 (0.77, 1.47)
Other 1.00 (0.87, 1.15) 1.20 (1.01, 1.42)
Previous DSH presentations
None 1.0 1.0
One 3.02 (2.72, 3.35) 3.04 (2.76, 3.34)
Two 3.99 (3.48, 4.58) 4.92 (4.33, 5.59)
Three 5.78 (4.89, 6.83) 6.36 (5.38, 7.52)
Four 6.74 (5.24, 8.67) 8.09 (6.71, 9.76)
doi:10.1371/journal.pone.0031663.t001
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